Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × ganitumab × Sarcoma × Clear all

Status

Terminated 3 Recruiting 2 Completed 2 No longer available 1 Active not recruiting 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Sarcoma, Ewing 1

Interventions

Trabectedin 2 tazemetostat 1 regorafenib 1 omburtamab I-131 1 nirogacestat 1 ganitumab 1 fludarabine phosphate 1 avapritinib 1 Whole-Body Irradiation 1 Tacrolimus 1 TH 302 1 Mycophenolic Acid 1 Everolimus 1 DOXO-EMCH 1 Cytarabine 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03029481 2019-03-28

Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma

Jonsson Comprehensive Cancer Center

No longer available

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡